INVO Fertility (IVF) Cost of Revenue (2011 - 2026)

INVO Fertility (IVF) has reported Cost of Revenue for 16 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 24.04% year-over-year to $1.4 million in Q2 2026; TTM through Jun 2026 was $4.8 million, a 17.55% increase from a year earlier, with the FY2025 full-year figure at $4.3 million, up 17.46% from the prior year.
• Cost of Revenue was $1.4 million for Q2 2026 at INVO Fertility, up from $1.3 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $1.4 million in Q2 2026 and troughed at $64961.0 in Q1 2022.
• A 5-year average of $736632.9 and a median of $893646.0 in 2023 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue soared 1119.4% in 2022 and advanced 2.17% in 2024, its largest moves.
• Over 5 years, Cost of Revenue stood at $234586.0 in 2022, then jumped by 294.39% to $925187.0 in 2023, then climbed by 2.17% to $945218.0 in 2024, then rose by 7.48% to $1.0 million in 2025, then surged by 33.15% to $1.4 million in 2026.
• The last three Cost of Revenue figures came in at $1.4 million (Q2 2026), $1.3 million (Q1 2026), and $1.0 million (Q4 2025), per Business Quant data.